Apollo Intelligence

@ApolloIntell · 16s “We’re extremely honored that, after making the 2022 Inc. 5000 Regionals: Northeast list, Apollo’s exemplary performance was worthy of the national 2022 Inc. 5000 list as well" via our very own Daniel S. Fitzgerald #inc5000 @Inc bit.ly/3PydbVv

We are pleased to share that Apollo Intelligence has been acquired by @FrazierHealth. Frazier’s acquisition will accelerate Apollo’s strategy for bringing transformative change to the healthcare and life science industries. bit.ly/3Q3NM7H

Excited for Day 1 of #bhbia2022? So are we! Stop by booth # 18 and meet our amazing InCrowd team! @crowdtalk

Wondering how to reach the prescriber in 2022? Apollo's Colin Turner-Kerr talks engaging HCPs in the COVID-endemic era in @pharmalive #prescriber #covid19 #endemic pharmalive.com/the-prescribe…

We, at Apollo, SHG, and InCrowd, stand with the Ukrainian people in their fight for self-determination. Their fortitude through this crisis inspires us all to remember how precious our freedom is and how vital it is to protect. Boh z toboyu! #WeStandWithUkraine

We are looking forward to bringing next level insights to our healthcare and life science partners through our transformative new collaboration with SightX. ow.ly/Gx1350FmU5S

We couldn't be more proud of Apollo Intelligence CEO Dan Fitzgerald for being named one of the 2021 #PM360ELITE 100 by PM360 Magazine for over 25-years of progressive innovation and leadership in market research. Well-deserved, Dan! ow.ly/MV2L50EMIeM

Congratulations to our Meghan Oates-Zalesky for being recognized as an inspirational leader in the life sciences industry for @PharmaVOICE's second annual Woman of Influence feature. What a way to follow up Women's History Month! #WomensHistory #WomenInHealthcare

Watch our #Healthcare Predictions webinar for key insights from the physician community on the impact of #COVID-19 and our path back to normalcy in the year ahead. bit.ly/3dpGoTn